First-In-Man, Healthy Volunteer Study to Evaluate Safety on the Use of YQ23

Summary

This study is to test the safety, tolerability, pharmacokinetics (PK-the amount of study drug in the blood), and immunogenicity (how the study drug affects the immune system) of single dose and dose levels of an investigational drug called YQ23.

Timeline

Start

2019-01-16

Primary completion

2020-09-20

Completion

2020-11-20

Drugs

Indications

No indication recorded.